October 28, 2026
The head of the U.S. Patent and Trademark Office has turned down Pogona LLC's argument that Merck's challenge to a patent on selecting a type of bacteria to use in a vaccine against pneumococcal disease was an "abusive" attack on the patent.
October 20, 2026
In his latest round of decisions, U.S. Patent and Trademark Office Director John Squires has granted 10 petitions seeking review of patents and denied two others, both on discretionary grounds.
September 24, 2026
In his latest round of decisions, U.S. Patent and Trademark Office Director John Squires has granted five petitions seeking reviews of patents, while turning down six other requests: three for discretionary reasons and three on the merits.